APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 1.5mg capsule bottle

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

rivastigmine hydrogen tartrate, Quantity: 2.4 mg

제공처:

Arrotex Pharmaceuticals Pty Ltd

INN (국제 이름):

rivastigmine hydrogen tartrate

약제 형태:

Capsule

구성:

Excipient Ingredients: titanium dioxide; stearic acid; iron oxide yellow; maize starch; Gelatin; microcrystalline cellulose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

관리 경로:

Oral

패키지 단위:

100, 56, 500

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer's type

제품 요약:

Visual Identification: Hard gelatine calsule with yellow, opaque body and yellow opaque cap. Imprinted "APO R1.5" in black ink, white to off white fill.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

승인 상태:

Licence status A

승인 날짜:

2010-07-27